Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets

PLoS ONE

Volumn 2, Issue 9, 2007, Pages

  Gururajan, Murali ^a   Jacob, Joshy ^a,b   Pulendran, Bali ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIBODY; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; HELPER CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VITRO STUDY; MEMORY CELL; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PEYER PATCH; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SPLEEN LYMPHOCYTE; ANIMAL; C57BL MOUSE; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MUCOSA; POLYMERASE CHAIN REACTION; SPLEEN;

MURINAE;

ANIMALS; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; MUCOUS MEMBRANE; POLYMERASE CHAIN REACTION; SPLEEN; TOLL-LIKE RECEPTORS;

EID: 41149150143     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000863     Document Type: Article

References (29)

1. Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-680.
2. Beutler B (2005) The Toll-like receptors: analysis by forward genetic methods. Immuntogenetics 57: 385-392.
3. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987-995.
4. Pulendran B (2004) Modulating, vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev 199: 227-250.
5. Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, et al. (2003) Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33: 827-833.
6. Ito T, Liu YJ, Kadowaki N (2005) Functional diversity and plasticity of human dendritic cell subsets. Int J Hematol 81: 188-196.
7. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, et al. (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863-869.
8. Pasare C, Medzhitov R (2005) Control of B-cell responses by Toll-like receptors. Nature 438: 364-368.
9. Whitlock CA, Watson JD (1979) B-cell differentiation in the CBA/N mouse. I. Slower maturation of mitogen and antigen-responsive B cells in mice expressing an X-linked defect. J Exp Med 150: 1483-1497.
10. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549.
11. Janeway CA Jr, Medzhitov R (1999) Lipoproteins take their toll on the host. Curt Biol 9: R879-882.
12. Bernasconi NL, Onai N, Lanzavecchia A (2003) A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 4500-4504.
13. Huggins J, Pellegrin T, Felgar RE, Wei C, Brown M, et al. (2007) CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood 109: 1611-1619.
14. Mansson A, Adner M, Hockerfelt U, Cardell LO (2006) A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. Immunology 118: 539-548.
15. Martin F, Kearney JF. (2002) Marginal-zone B cells. Nat Rev Immunol 2: 323-335.
16. Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF (1997) Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 27: 2366-2374.
17. Kiyono H, Fukuyama S (2004) NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 4: 699-710.
18. Berland R, Wortis HH (2002) Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20: 253-300.
19. Chappell CP, Jacob T (2006) Identification of memory B cells using a novel transgenic mouse model. J Immunol 176: 4706-4715.
20. Shinall SM, Gonzalez-Fernandez M, Noelle RJ, Waldschmidt TJ (2000) Identification of murine germinal center B cell subsets defined by the expression of surface isotypes and differentiation antigens. J Immunol 164: 5729-5738.
21. Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, et al. (2004) A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 172: 4733-4743.
22. Napolitani G, Rinaldi A. Bertoni F Sallusto F Lanzavecchia A (2005) Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 6: 769-776.
23. Vitetta ES, McWilliams M, Phillips-Quagliata JM, Lama ME, Uh JW, (1975) Cell surface immunoglobulin. XIV. Synthesis, surface expression, and secretion of immunoglobulin by Peyer's patch cells in the mouse. J Immunol 115: 603-605.
24. Bekeredjian-Ding IB, Wagner M, Hornung V, Giese T, Schnurr M, et al. (2005) Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol 174: 4043-4050.
25. Genestier L, Taillardet M, Mondirre P, Gheit H, Bella C, et al. (2007) TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol 178: 7779-7786.
26. Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, et al. (2004) Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol 34: 251-262.
27. Gavin AL, Hoebe K, Duong B, Ota T, Martin C, et al. (2006) Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314: 1936-1938.
28. Fink K, Lang KS, Manjarrez-Orduno N, Junt T, Seem BM, et al. (2006) Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses. Eur J Immunol 36: 2094-2105.
29. Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, et al. (2006) Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203: 413-424.